GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Acino Holding AG (FRA:S3H) » Definitions » Debt-to-Equity

Acino Holding AG (FRA:S3H) Debt-to-Equity : 0.40 (As of Dec. 2013)


View and export this data going back to . Start your Free Trial

What is Acino Holding AG Debt-to-Equity?

Acino Holding AG's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2013 was €12.3 Mil. Acino Holding AG's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2013 was €95.9 Mil. Acino Holding AG's Total Stockholders Equity for the quarter that ended in Dec. 2013 was €273.1 Mil. Acino Holding AG's debt to equity for the quarter that ended in Dec. 2013 was 0.40.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Acino Holding AG's Debt-to-Equity or its related term are showing as below:

FRA:S3H' s Debt-to-Equity Range Over the Past 10 Years
Min: 0   Med: 0   Max: 0
Current: 0.4

FRA:S3H's Debt-to-Equity is not ranked
in the Drug Manufacturers industry.
Industry Median: 0.3 vs FRA:S3H: 0.40

Acino Holding AG Debt-to-Equity Historical Data

The historical data trend for Acino Holding AG's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acino Holding AG Debt-to-Equity Chart

Acino Holding AG Annual Data
Trend Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 0.42 0.40

Acino Holding AG Semi-Annual Data
Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - - - 0.42 0.40

Competitive Comparison of Acino Holding AG's Debt-to-Equity

For the Drug Manufacturers - General subindustry, Acino Holding AG's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Acino Holding AG's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Acino Holding AG's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Acino Holding AG's Debt-to-Equity falls into.



Acino Holding AG Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Acino Holding AG's Debt to Equity Ratio for the fiscal year that ended in Dec. 2013 is calculated as

Acino Holding AG's Debt to Equity Ratio for the quarter that ended in Dec. 2013 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Acino Holding AG  (FRA:S3H) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Acino Holding AG Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Acino Holding AG's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Acino Holding AG (FRA:S3H) Business Description

Traded in Other Exchanges
N/A
Address
Acino Holding AG is a Switzerland-based company engaged in the pharmaceutical industry. The Company develops, manufactures, and markets pharmaceuticals in novel drug delivery forms internationally. It is divided into four segments Business to Consumer (BtC); Business to Business (BtB); Technology marketing (TM); and Production (Prod). The BtC segment comprises all direct marketing activities. Under the company's "Acino Switzerland" brand and, with the promise of Swiss quality, the company sells its products in emerging markets around the globe. This reporting segment includes the business purchased from Mepha/Cephalon in the Middle East, Africa, Latin America and Asia. The BtB segment comprises Acino's business with its internally developed products, for which the company also owns the intellectual property rights. Acino develops and produces high-quality medicines with proven active ingredients and modern drug delivery systems and grants licenses for them to leading pharmaceutical and generic pharmaceutical companies worldwide. The technology marketing segment comprises a broad spectrum of fully integrated contract services, including procurement, contract development, production and packaging for companies in the life sciences industry. On behalf of these customers, Acino develops a comprehensive product pipeline on the basis of its special technological know-how. This includes both new types of medicines as well as projects with innovative drug delivery systems for established active ingredients. The production segment is responsible for the manufacturing of products and the supplying of the other three segments, and generates turnover through the reimbursement of its services. The manufacturing costs of products are credited to the production segment at standard prices along with remuneration in the form of a mark-up for materials and production costs.

Acino Holding AG (FRA:S3H) Headlines

No Headlines